Screening identified 2-(3-((4,6-dioxo-2-thioxotetrahydropyrimidin-5(2H)-ylidene)methyl)-2,5-dimethyl-1H-pyrrol-1-yl)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile as an MDM2–p53 inhibitor (IC50 = 12.3 μM). MDM2–p53 and MDMX–p53 activity was seen for 5-((1-(4-chlorophenyl)-2,5-diphenyl-1H-pyrrol-3-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (MDM2 IC50 = 0.11 μM; MDMX IC50 = 4.2 μM)
筛选鉴定出 2-(3-((4,6-dioxo-2-thioxotetrahydropyrimidin-5( 2H )-ylidene)methyl)-2,5-dimethyl- 1H -pyrrol-1-yl)-4,5, 6,7-四氢苯并[ b ]
噻吩-3-甲腈作为 M
DM2-
p53 抑制剂 (IC 50 = 12.3 μM)。M
DM2-p53 和 M
DMX-p53 活性观察到 5-((1-(4-chlorophenyl)-2,5-diphenyl-1 H -pyrrol-3-yl)methylene)-2-thioxdihydropyrimidine-4,6(1 H ,5 H )-二酮 (M
DM2 IC 50 = 0.11 μM;M
DMX IC 50 = 4.2 μM) 和 5-((1-(4-nitrophenyl)-2,5-diphenyl-1 H -pyrrol-3-yl)亚甲基)
嘧啶-2